Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play.  | BioDuro, headquartered in ...

1. FDA. FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. FDA News Release. March 3, 2026.

Due to the impact of portfolio rationalization, and considering the challenging business environment, the company expects a ...

BioDuro, a CRDMO, has established a joint venture with Cenra API Solutions, a pharmaceutical chemical manufacturer in Taiwan.

Press Release Paris, 3rd March, 2026 Progress against FOCUS-27 in a deteriorating environment Accelerated transformation to strengthen the operating model Full-year 2025 results €848.2 million net ...

ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

While solely API-focused players currently face increased competition, this transition is expected to strengthen long-term pricing power, improve margins, enhance compliance, and increase customer ...

VISAKHAPATNAM: HRD and IT Minister Nara Lokesh performed the groundbreaking ceremony for a greenfield pharmaceutical ...

Apis Capital Advisors increased its stake in Garrett Motion, a key supplier of turbocharging systems used in combustion and hybrid vehicles. With global auto production still dominated by hybrid and ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...